Navigation Links
Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend

ST. LOUIS, Oct. 23 /PRNewswire-FirstCall/ -- Young Innovations, Inc. (Nasdaq: YDNT) today announced results for the quarter and nine months ended September 30, 2007.

Sales for the third quarter were $24.7 million, increasing 3.5% over the $23.8 million reported for the third quarter of 2006. Income from operations decreased 16.8% to $5.2 million from $6.2 million in the prior year. Net income of $3.1 million decreased 22.1% from $3.9 million in the prior year. Diluted earnings per share for the third quarter of 2007 were $0.35, a decrease of 18.6% over the $0.43 reported in the prior year quarter. For the quarter ended September 30, 2007, diluted shares outstanding were 8,773,000 a decrease of 410,000 shares over the prior year, principally reflecting the pro rata impact of the 1 million share repurchase completed on August 15, 2007. Diluted earnings per share were affected by equity compensation expense of $0.02 and $0.01 for the quarters ended September 30, 2007 and 2006, respectively.

For the nine months ended September 30, 2007, sales were $72.4 million, increasing 9.7% from the prior year period. Income from operations for the nine months ended September 30, 2007 decreased 9.4% to $15.7 million from $17.3 million in the prior year. Net income was $9.4 million, decreasing 15.5% from $11.1 million in the year earlier nine-month period. Diluted earnings per share were $1.03 for the nine months ended September 30, 2007, a decrease of 14.9% from $1.21 in the same period of 2006. For the nine months ended September 30, 2007, diluted shares outstanding were 9,082,000 a decrease of 96,000 shares over the prior year, principally reflecting the pro rata impact of the 1 million share repurchase completed on August 15, 2007. Diluted earnings per share were affected by equity compensation expense of $0.05 and $0.02 for the nine months ended September 30, 2007 and 2006, respectively.

The results for the quarter were affected by the acquisition of the assets of Microbrush, Inc. and Microbrush International, Ltd. (collectively "Microbrush"), completed on July 31, 2006, and August 18, 2006, respectively. Microbrush contributed approximately $3.6 million in sales in the third quarter of 2007, as compared to $2.0 million in the third quarter of 2006. For the nine months ended September 30, 2007, Microbrush contributed $11.0 million in sales, as compared to $2.0 million in the prior year period.

The sales growth in the quarter reflected the incremental sales from Microbrush offset by lower sales of certain products to distributors. While end-user demand for these products appears stable, volatile distributor purchase patterns continue to impact quarterly sales.

As productivity in our Earth City facility has increased faster than market demand, we reduced production in the quarter to bring inventory levels more in line with demand. In addition, we maintained staffing levels and incurred costs related to preparing for future consolidations. We believe this activity impacted our diluted earnings per share by approximately $0.04 in the quarter.

Commenting on the quarter, Alfred E. Brennan, Chief Executive Officer, said, "During the quarter, we managed through a difficult operating environment as we continued to integrate the acquisition of Microbrush, completed the repurchase of 1 million shares from our Chairman, adjusted production and inventory levels at our Earth City facility and prepared for future facilities consolidations. We believe we have made good progress in expanding our sales and marketing capacity and executing on the consolidation plans outlined earlier in the year."

On October 22, 2007, the Board of Directors declared a quarterly dividend of $0.04 per share, payable on December 14, 2007 to shareholders of record on November 15, 2007.

A conference call has been scheduled for Wednesday, October 24, 2007 at 11:00 A.M. Central Time and can be accessed through InterCall at or on the Company's website,

Young Innovations develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, panoramic X-ray machines, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. The Company believes it is the leading manufacturer and distributor of prophy angles and cups (used in teeth cleaning and polishing procedures), liquid surface disinfectants, obturation units, and dental micro-applicators in the United States. The Company also believes it is the leading distributor of panoramic X-ray equipment in the United States.

Investors are cautioned that this press release as well as other reports and oral statements by Company officials may contain certain forward-looking statements as defined in the Private Securities Litigation and Reform Act of 1995. Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions and which include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," or similar expressions. These statements are not guaranties of future performance and the Company makes no commitment to update or disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements. Because such statements involve risks and uncertainties, actual actions and strategies and the timing and expected results thereof may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, those disclosed in the Company's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

Young Innovations, Inc.

Condensed Consolidated Statements of Income

(In Thousands, Except Earnings Per Share Data)


Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 Change 2007 2006 Change

Net Sales $24,652 $23,811 3.5% $72,361 $65,960 9.7%

Cost of Goods Sold 11,900 11,045 7.7% 33,675 30,130 11.8%

Gross Profit 12,752 12,766 -0.1% 38,686 35,830 8.0%

% of Net Sales 51.7% 53.6% 53.5% 54.3%

Selling, General and


Expense 7,601 6,578 15.6% 23,005 18,524 24.2%

% of Net Sales 30.8% 27.6% 31.8% 28.1%

Income from Operations 5,151 6,188 -16.8% 15,681 17,306 -9.4%

% of Net Sales 20.9% 26.0% 21.7% 26.2%

Interest expense

(income), net 358 71 761 (232)

Other expense

(income), net 33 - 51 (80)

Income before taxes 4,760 6,117 -22.2% 14,869 17,618 -15.6%

Provision for Income

Taxes 1,685 2,169 5,501 6,536

Net Income $3,075 $3,948 -22.1% $9,368 $11,082 -15.5%

% of Net Sales 12.5% 16.6% 12.9% 16.8%

Basic Earnings Per

Share $0.36 $0.44 -18.2% $1.05 $1.24 -15.3%

Basic Weighted Average

Shares Outstanding 8,600 8,963 8,928 8,941

Earnings Per Share

(Diluted) $0.35 $0.43 -18.6% $1.03 $1.21 -14.9%

Diluted Weighted

Average Shares

Outstanding 8,773 9,183 9,082 9,178

Young Innovations, Inc.

Consolidated Balance Sheet

September 30, 2007 and December 31, 2006

(In Thousands)


September 30 December 31

Assets 2007 2006

Current assets

Cash $2,292 $1,017

Accounts receivable, net 13,532 13,057

Inventories 14,310 14,111

Other current assets 4,700 5,546

Total current assets 34,834 33,731

Property, plant and equipment, net 33,196 29,178

Goodwill 77,511 78,233

Intangible assets 11,266 11,140

Other assets 4,544 4,306

Total assets $161,351 $156,588

Liabilities and Equity

Current liabilities

Accounts payable and accrued liabilities $9,976 $7,749

Total current liabilities 9,976 7,749

Long-term debt 41,000 21,810

Deferred income taxes 10,086 9,531

Other liabilities 455 -

Total liabilities 61,517 39,090

Stockholders' equity

Common stock 90 90

Additional paid-in capital 27,413 29,214

Retained earnings 119,394 111,089

Common stock in treasury, at cost (47,217) (22,939)

Accumulated other comprehensive income 154 44

Total stockholders' equity 99,834 117,498

Total liabilities and stockholders' equity $161,351 $156,588

SOURCE Young Innovations, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Young womens woes
2. Young womens woes
3. Eat Vitamin C and stay young
4. Viagra Used More By Young Men
5. Movies Influence Youngsters To Drink
6. Stay young the Chinese way
7. Have sex and stay young
8. Bronchitis in the young
9. Zinc may enhance growth in Young sickle cell patients
10. Smoke less to stay young
11. Young women prone to heart attack
Post Your Comments:
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced today that ... Somu now offers travelers, value and care based Travel Services, including exclusive pricing ... well as, cabin upgrades and special amenities such as, shore excursions, discounted fares, ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... medical opinion process, participated in the 61st annual Employee Benefits Conference. The Employee ... took place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... potentially more aggressive than those found on mammography, according to a study published ... of additional cancers not seen on mammography may necessitate a change in treatment. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
Breaking Medicine Technology: